Foreign Drug Inspection Program A hearing was held on the circumstances surrounding the contamination of heparin imported from China. According to the FDA, 81 people have died… read more

Foreign Drug Inspection Program A hearing was held on the circumstances surrounding the contamination of heparin imported from China.

According to the FDA, 81 people have died after allergic reactions to the

anticoagulant drug heparin since January 2007. Family members of victims who died after being treated with heparin testified. Dr. Woodcock testified

that with outsourcing of drug production to countries such as India and

China, the FDA is not currently configured to regulate global markets, and the

FDA’s inspection coverage is underfunded. Representative from two

companies responsible for introducing the contaminated heparin into the

U.S. also testified.

Witnesses responded to questions from committee members. close

People in this video

  • Deborah M. Autor Compliance Director U.S. Food and Drug Administration->Center for Drug Evaluation and Research
  • Regina Brown Inspector U.S. Food and Drug Administration->Center for Drug Evaluation and Research
More People

Hosting Organization

More information about

Foreign Drug Inspection Program

476 Views
Program ID:
205093-1
Category:
House Committee
Format:
House Committee
Location:
Washington, District of Columbia, United States
First Aired:
Apr 29, 2008 | 12:50pm EDT | C-SPAN 1
Last Aired:
May 03, 2008 | 3:36pm EDT | C-SPAN 1

Airing Details

  • Apr 29, 2008 | 12:50pm EDT | C-SPAN 1
  • Apr 29, 2008 | 9:20pm EDT | C-SPAN 2
  • Apr 30, 2008 | 3:40am EDT | C-SPAN 1
  • May 02, 2008 | 10:56am EDT | C-SPAN 3
  • May 03, 2008 | 3:36pm EDT | C-SPAN 1
Purchase a DVD or Download

Foreign Drug Inspection Program

  • DVD
    Price:
    $59.90
  • MP4 video - Low
    Price:
    Free
  • MP4 video - Standard
    Price:
    $6.99
  • MP3 audio - Standard
    Price:
    $0.99

User Created Clips from This Video